Reliance Life Sciences plans Rs.1,500 crore manufacturing facilityIllustrative image – not actual.

Reliance Life Sciences is planning to set up a manufacturing facility for re-combinant protiens and cell therapies at Navi Mumbai in Maharashtra. It would entail an investment of Rs.1,500 crore.

The company aims to set up dedicated centres for high-end research and manufacturing of specialty therapeutic products and will mainly focus on embryonic and haematopoietic stem cells, skin and tissue engineering, plant tissue culture, molecular diagnostics, biofuels and monoclonal antibodies.

It will also focus on therapies in the treatment of Thalassemia, leukaemia and sickle cell anemia through stem cell research.

Reliance Life Sciences is also planning to set up an animal house to conduct regulatory toxicology and pre-clinical efficacy studies for cell-based therapies.

 

 

 

 

← All latest storiesBack to top →